Morphic Holding Inc (MORF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MORF | BMY | AMGN | REGN | GILD |
| Company | Morphic Holding Inc | Bristol-Myers Squibb Company | Amgen Inc | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 29.05 | 49.00 | 270.63 | 906.90 | 66.58 |
| High | 29.05 | 49.04 | 274.86 | 915.70 | 67.18 |
| Low | 27.55 | 48.55 | 269.64 | 904.41 | 66.36 |
| Last | 27.69 | 48.86 | 273.01 | 906.54 | 67.08 |
| Change | -1.06 | -0.13 | -0.53 | -0.78 | +0.05 |
| % Change | -3.69% | -0.27% | -0.19% | -0.09% | +0.07% |
| Volume | 332,732 | 16,051,517 | 2,465,818 | 373,548 | 8,464,430 |
| 20-Day Average Volume | 401,157 | 11,258,831 | 2,172,641 | 441,812 | 6,490,406 |
| Previous Close | 28.75 | 48.99 | 273.54 | 907.32 | 67.03 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 30.09 | 50.37 | 271.55 | 926.29 | 69.07 |
| 20-Day Raw Stochastic | 6.75% | 18.15% | 44.22% | 18.66% | 14.81% |
| 20-Day Relative Strength | 38.20% | 41.15% | 48.18% | 39.46% | 33.12% |
| Weighted Alpha | -17.51 | -26.02 | +11.15 | +13.86 | -20.78 |
| Today's Opinion | 72% Sell | 88% Sell | 40% Sell | 24% Buy | 100% Sell |
| Previous Opinion | 72% Sell | 88% Sell | 40% Sell | 24% Buy | 100% Sell |
| Last Month's Opinion | 24% Sell | 8% Sell | 24% Buy | 80% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.65% since 04/17/24 | +2.13% since 04/17/24 | +3.39% since 04/17/24 | +0.59% since 04/17/24 | +0.22% since 04/17/24 |
| Low | 27.12 on 04/19/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 891.46 on 04/19/24 | 65.90 on 04/18/24 |
| High | 29.59 on 04/23/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 920.73 on 04/19/24 | 67.68 on 04/23/24 |
| 1-Month | |||||
| %Chg | -16.70% since 03/22/24 | -5.91% since 03/22/24 | -1.14% since 03/22/24 | -6.28% since 03/22/24 | -7.62% since 03/22/24 |
| Low | 27.12 on 04/19/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 890.43 on 04/16/24 | 65.90 on 04/18/24 |
| High | 35.56 on 04/01/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 976.75 on 03/27/24 | 73.87 on 03/28/24 |
| 3-Month | |||||
| %Chg | -2.02% since 01/24/24 | -2.75% since 01/24/24 | -10.64% since 01/24/24 | -4.40% since 01/24/24 | -15.65% since 01/24/24 |
| Low | 27.12 on 04/19/24 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 890.43 on 04/16/24 | 65.90 on 04/18/24 |
| High | 41.47 on 02/12/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 998.33 on 02/28/24 | 81.06 on 01/25/24 |
| 6-Month | |||||
| %Chg | +35.14% since 10/24/23 | -12.94% since 10/24/23 | -1.13% since 10/24/23 | +12.71% since 10/24/23 | -14.17% since 10/24/23 |
| Low | 19.34 on 11/01/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 769.19 on 10/27/23 | 65.90 on 04/18/24 |
| High | 41.47 on 02/12/24 | 56.77 on 10/25/23 | 329.72 on 02/05/24 | 998.33 on 02/28/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,438,564 | 99,290,928 | 146,720,288 | 99,589,264 | 83,457,512 |
| Shares Outstanding, K | 50,037 | 2,026,759 | 536,376 | 109,762 | 1,245,077 |
| Annual Sales | 520,000 | 45,006,000,000 | 28,190,000,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -152,100,000 | 8,025,000,000 | 6,717,000,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 11,477,000,000 | 8,196,000,000 | 3,434,300,000 | 7,114,000,000 |
| Last Quarter Net Income | -40,730,000 | 1,762,000,000 | 767,000,000 | 1,159,600,000 | 1,429,000,000 |
| 60-Month Beta | 1.42 | 0.39 | 0.58 | 0.11 | 0.19 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.94 on 02/22/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 11.86 on 02/02/24 | 1.72 on 02/06/24 |
| Latest Earnings Date | 04/23/24 | 04/25/24 | 05/02/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | N/A | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | N/A | 03/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.55 | 14.58 | 23.95 | 9.96 |